Clinical trials interactive, video-based education made available to patients and caregivers with blood cancers on

The Leukemia & Lymphoma Society (LLS) will present a free video education program for patients and caregivers that will help explain how to join clinical trials and what to expect when participating. Clinical Trials for Blood Cancers: How can participating in a clinical trial help me?’ will air live online on Wednesday, April 18, 2018 at 12:00PM ET on and be available for on-demand viewing through 2019, providing people affected by blood cancers information about:

  • The role of clinical trials for blood cancers
  • When a clinical trial is a viable option
  • Benefits of clinical trials
  • Role of a patient and caregiver before, during and after the process
  • LLS’s Clinical Trials Support Center (CTSC)

“Clinical Trials are the only way the exciting breakthrough research we support at LLS can get to patients,” shared Gwen Nichols, MD Chief Medical Officer of The Leukemia and Lymphoma Society. “There is an urgent need for more patients to have access to these breakthroughs via participation in clinical trials. We need to make participation easier for patients and their health care team. Clinical trial participation should be an active part of cancer discussions starting at diagnosis, and no longer thought of as a ‘last resort’. Patients and caregivers educating themselves is a great step and LLS is here to help.”

Patients and caregivers who attend the live program will have multiple opportunities to interact with program panelists and each other. Prior to the program, patients can submit questions to the panel through the program’s QBoard. Once the live broadcast begins, participants can continue to submit questions through CancerCoachLive’s Q&A feature to be answered in real time, as well as participate in live audience polling. The 1-hour program will feature patients, caregivers and clinicians including John P Leonard, MD of Weill Cornell Medicine and New York-Presbyterian Hospital and Alissa Gentile, MSN, RN, Director of The Leukemia & Lymphoma Society’s Clinical Trial Support Center (CTSC).

Kathryn Pucci, Senior Vice President of Education at PlatformQ Health echoed the importance of clinical trial education for patients. “We’re thrilled to deliver this important patient program for The Leukemia & Lymphoma Society. Video education, especially with interactive live components, is well suited to help educate patients and caregivers about the benefits of becoming involved in clinical trials: this program can be accessed from anywhere, for free, and enables people to connect with some of the nations’ leading experts. We are happy to support The Leukemia & Lymphoma Society programming and help them track the impact of this education – together, we can increase participation and begin to include the patient perspective in clinical trial development.”

Patients will also have access to key LLS clinical trials resources through the program, as well as an opportunity to get one-on-one information about treatment, support, financial assistance and more through the LLS Clinical Trial Support Center.

Support for this program provided by Bristol-Myers Squibb, Celgene, Genentech & Biogen, Novartis, Stemline Therapeutics, Inc., and Takeda Oncology.

About The Leukemia & Lymphoma Society
The Leukemia & Lymphoma Society (LLS) is the world’s largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world and provides free information and support services.

About PlatformQ Health
PlatformQ Health is the leading provider of live, online medical education, operating 17 therapeutically aligned learning channels dedicated to providing clinicians, patients, caregivers, advocates and administrators rigorous, outcomes-centric education aimed at improving patient care. The company’s unique education platform allows physicians, healthcare professionals, patients and caregivers to connect online from anywhere to learn about the latest treatments options, and engage in real-time discussion with scientific, research and patient care experts. Learn more at